I2PETHV - Quantification and Localisation of Imidazoline2 Binding Sites in Healthy Volunteers Using [11C]BU99008 a Positron Emission Tomography Study

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT02323217

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:38:24.627717+00:00

Published At

2021-11-15T00:00:00+00:00

Record Updated At

2021-11-15

Results Posted At

2021-11-15

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Healthy Volunteers", "Alzheimer Disease", "Molecular Imaging"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2021-11-15"

protocolSection.identificationModule.nctId

"NCT02323217"

protocolSection.identificationModule.officialTitle

"I2PETHV - Quantification and Localisation of Imidazoline2 Binding Sites in Healthy Volunteers Using [11C]BU99008 a Positron Emission Tomography Study"

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

["EARLY_PHASE1"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

"2021-11-15"

Study condition terms

• Healthy Volunteers (protocolSection.conditionsModule.conditions)
• Alzheimer Disease (protocolSection.conditionsModule.conditions)
• Molecular Imaging (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.